19 March 2023 - Millions of Americans with diabetes have cheered as drug makers slashed the price of insulin, the life saving medication that treats the chronic disease.
But those lower prices, which came amid government pressure to cap insulin costs and more competition from generics and biosimilars, are only one part of the cost of treating the disease, which causes elevated blood sugar that can damage the heart, eyes and kidneys if untreated.
Over the counter medical supplies to monitor glucose levels and administer medications can make up the largest portion of a patient’s costs.